Investigation of Predictive Biomarkers in Patients With Advanced Biliary Tract Cancer Treated With Lenvatinib Plus Pembrolizumab
Latest Information Update: 22 Oct 2024
At a glance
- Drugs Lenvatinib (Primary) ; Pembrolizumab (Primary)
- Indications Biliary cancer
- Focus Pharmacodynamics
Most Recent Events
- 22 Oct 2024 New trial record